| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/01/2001 | WO2001014338A1 NOVEL INTEGRIN αVβ3 INHIBITORS |
| 03/01/2001 | WO2001014337A1 αvβ3 INTEGRIN INHIBITORS |
| 03/01/2001 | WO2001014333A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 03/01/2001 | WO2001014320A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | WO2001014318A2 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | WO2001013967A1 Solid wound healing formulations containing fibronectin |
| 03/01/2001 | WO2001013957A2 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | WO2001013926A2 Superoxidized water based on hypochlorous acid for the treatment of wounds |
| 03/01/2001 | WO2001013901A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 03/01/2001 | WO2001013878A1 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 03/01/2001 | WO2001013873A1 Composition for topical administration comprising 5-methoxypsoralen |
| 03/01/2001 | WO2001013865A1 Pharmaceutical compositions and methods for reducing the appearance of cellulite |
| 03/01/2001 | WO2000073445A3 Interleukin-1-receptor associated kinase-3 (irak3) |
| 03/01/2001 | WO2000068223A8 Ureas and their use as cell adhesion modulators |
| 03/01/2001 | WO2000045802A3 Use of (alpha)-d-glucans for promoting cutaneous wound and ulcer healing |
| 03/01/2001 | DE19941186A1 Sequenz-spezifische DNA-Rekombination in eukaryotischen Zellen Sequence-specific DNA recombination in eukaryotic cells |
| 03/01/2001 | DE19940748A1 Arzneimittel enthaltend xenogene Oligo- oder/und Polyribonukleotide Medicament comprising xenogenic oligo- or / and polyribonucleotides |
| 03/01/2001 | DE19940130A1 Neue Effektoren der Dipeptidyl Peptidase IV zur topischen Anwendung New effectors of dipeptidyl peptidase IV for topical use |
| 03/01/2001 | DE19939981A1 Neue Inhibitoren des Integrins alphavß3 New inhibitors of integrin alphavß3 |
| 03/01/2001 | DE19939980A1 Inhibitoren des Integrins alphavbeta¶3¶ Inhibitors of integrin alphavbeta¶3¶ |
| 03/01/2001 | DE19939910A1 Neue Verbindungen, die Tryptase-Aktivität hemmen Novel compounds that inhibit tryptase activity |
| 03/01/2001 | CA2383559A1 Inhibitors of binding between proteins and macromolecular ligands |
| 03/01/2001 | CA2382850A1 Novel inhibitors of the integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382674A1 Gas1 polypeptides |
| 03/01/2001 | CA2382561A1 Inhibitors of integrin .alpha.v.beta.3 |
| 03/01/2001 | CA2382430A1 Use of bacterial extracts of the pseudomonadaceae family as cosmetic agents |
| 03/01/2001 | CA2382300A1 Composition for topical administration comprising 5-methoxypsoralen |
| 03/01/2001 | CA2382123A1 Novel polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 03/01/2001 | CA2381425A1 Enhancing drug delivery across and into epithelial tissues using oligo arginine moieties |
| 03/01/2001 | CA2381096A1 Compounds that inhibit tryptase activity |
| 03/01/2001 | CA2380730A1 Solid wound healing formulations containing fibronectin |
| 03/01/2001 | CA2379875A1 New effectors of dipeptidyl peptidase iv for topical use |
| 03/01/2001 | CA2376297A1 Methods of obtaining 2-methoxyestradiol of high purity |
| 03/01/2001 | CA2376293A1 Imidazo[1,2-a]pyridine and pyrazolo[2,3-a]pyridine derivatives |
| 02/28/2001 | EP1078629A2 Use of Salmeterol and salts for the treatment of inflammation and allergy |
| 02/28/2001 | EP1078002A1 Peptide antiangiogenic drugs |
| 02/28/2001 | EP1077978A1 Novel substituted aryl hydroxamic acids as metalloproteinase inhibitors |
| 02/28/2001 | EP1077971A1 1,5-DIARYL SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS |
| 02/28/2001 | EP1077949A2 Combinations of protein farnesyltransferase and hmg coa reductase inhibitors and their use to treat cancer |
| 02/28/2001 | EP1077946A1 Fused tricyclic compounds which inhibit parp activity |
| 02/28/2001 | EP1077945A1 Isoquinolines as urokinase inhibitors |
| 02/28/2001 | EP1077943A1 Heterocyclic inhibitors of p38 |
| 02/28/2001 | EP1077940A1 4-phenylpiperidines for the treatment of pruritic dermatoses |
| 02/28/2001 | EP1077937A1 METHOD OF LOCKING 1$g(a)-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION |
| 02/28/2001 | EP1077936A1 Novel analogs of 16-hydroxyeicosatetraenoic acid |
| 02/28/2001 | EP1077931A1 Benzamide derivatives for the treatment of diseases mediated by cytokines |
| 02/28/2001 | EP1077717A2 Use of lipopeptides or lipoproteins for wound treatment |
| 02/28/2001 | EP1077711A2 Treatment of papilloma virus infection using a mycobacterium |
| 02/28/2001 | EP1077675A1 Therapeutic compositions |
| 02/28/2001 | EP1077674A1 Topical composition |
| 02/28/2001 | CN1285874A Desaturase genes and their use |
| 02/28/2001 | CN1285845A VEGI, an inhibitor of angiogenesis and tumor growth |
| 02/28/2001 | CN1285751A Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 02/28/2001 | CN1285215A No scar remained burn and scald medicine |
| 02/28/2001 | CN1285210A Process for preparing crude drugs external cleaning liquid disinfectant and products thereof |
| 02/28/2001 | CN1285204A Ointment for treating burn and scald |
| 02/28/2001 | CN1285200A External medicine for treating sore caused by shell wound all bullet wound |
| 02/28/2001 | CN1285197A Paint liquid medicine for skin recovery of burn and scald and preparation process thereof |
| 02/28/2001 | CN1285193A preparing and application of oral hyaluronic acid skin-beautifying health care preparation |
| 02/28/2001 | CN1285186A Novel preparation for local use |
| 02/28/2001 | CN1062562C Corticosteroid 17-alkyl carbonate 21-[0]-carboxylic and carbonic esters, processes for their preparation, and pharmaceuticals containing these compounds |
| 02/27/2001 | USRE37078 Antiinflammatory agents, antiarthritic agents |
| 02/27/2001 | US6194578 Growth hormone secretagogues; useful for prophylaxis and therapy of osteoporosis and/or frailty, insulin resistance in mammals, congestive heart failure, obesity, accelerating bone fracture repair reducing cachexia and protein loss |
| 02/27/2001 | US6194468 Including p-menthane-3,8-diol, which has the action of promoting percutaneous absorption, and at least one blood circulation promoter to stimulate hair growth; does not cause side effects |
| 02/27/2001 | US6194458 1-(2-methoxyphenyl)-1-oxo-2-aza-(s)-4-i-butyl-4-phenylbutane, for example; treating various conditions including transplantation rejection of organs or tissues in a patient; immunosuppressant compositions |
| 02/27/2001 | US6194450 Polyaromatic heterocyclic compounds and pharmaceutical compositions comprised thereof |
| 02/27/2001 | US6194448 N, N-disubstituted amides that inhibit the binding of integrins to their receptors |
| 02/27/2001 | US6194440 Small molecule carbamate or urea hair growth compositions and uses |
| 02/27/2001 | US6194431 Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
| 02/27/2001 | US6194425 Viricides, antitumor agents |
| 02/27/2001 | US6194401 Pharmaceutical compositions containing cyclosporine and a carrier comprising at least an ester of α-glycerophosphoric acid |
| 02/27/2001 | US6194392 Administering to a patient suffering from swelling associated with brain tumours involving tissue of the group consisting of underperfused tissue and pathological tissue an antiswelling agent and a hyaluronic acid to aid penetration |
| 02/27/2001 | US6194388 Immunomodulatory oligonucleotides |
| 02/27/2001 | US6193975 Use of potentilla erecta extract in the cosmetic and pharmaceutical field |
| 02/27/2001 | US6193957 For prophylaxis and therapy of airway hyperresponsiveness or inflammatory reactions, e.g., asthma, allergic rhinitis, allergic dermatitis, allergic conjunctivitis, inflammatory bowel disease or rheumatoid arthritis |
| 02/27/2001 | CA2194370C Attenuation of wound healing processes |
| 02/22/2001 | WO2001013112A1 Melanocortin metallopeptide constructs, combinatorial libraries and applications |
| 02/22/2001 | WO2001012819A2 Protein phosphatases and diagnosis and treatment of phosphatase-related disorders |
| 02/22/2001 | WO2001012790A2 Isomerase proteins |
| 02/22/2001 | WO2001012786A1 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 02/22/2001 | WO2001012775A2 25 human secreted proteins |
| 02/22/2001 | WO2001012665A2 Helical cytokine zalpha48 |
| 02/22/2001 | WO2001012664A2 Notch receptor ligands and uses thereof |
| 02/22/2001 | WO2001012633A1 Water soluble sdz-rad esters |
| 02/22/2001 | WO2001012621A1 INHIBITORS OF c-JUN N-TERMINAL KINASES (JNK) AND OTHER PROTEIN KINASES |
| 02/22/2001 | WO2001012618A1 Dihydroaminobenzo[b]- and [c]furans as retinoid-like agents |
| 02/22/2001 | WO2001012611A1 Pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 02/22/2001 | WO2001012606A2 Tetrahydroquinoline derivatives having retinoid-like biological activity |
| 02/22/2001 | WO2001012603A1 Indole derivatives, process for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 02/22/2001 | WO2001012598A2 METHODS OF INHIBITING BINDING OF β-SHEET FIBRIL TO RAGE AND CONSEQUENCES THEREOF |
| 02/22/2001 | WO2001012592A2 Hydroxamic acid compounds useful as matrix metalloproteinase inhibitors |
| 02/22/2001 | WO2001012264A2 Topical azathioprine for the treatment of oral autoimmune diseases |
| 02/22/2001 | WO2001012243A1 Sterilized cyanoacrylate solutions containing thickeners |
| 02/22/2001 | WO2001012233A2 Sustained release formulation of a peptide |
| 02/22/2001 | WO2001012212A1 Inhibitors of the lectin complement pathway (lcp) and their use |
| 02/22/2001 | WO2001012206A2 Soy-glycine extracts and aromatase inhibitors for positively influencing collagen |
| 02/22/2001 | WO2001012193A1 Pharmaceutical agent comprising a benzamide derivative as active ingredient |
| 02/22/2001 | WO2001012189A1 3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/22/2001 | WO2001012188A1 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 02/22/2001 | WO2001012186A1 Cell adhesion inhibitors |